Expression of immune check point gene TIM‑3 in patients newly diagnosed with acute myeloid leukemia: Significance and impact on outcome-Reference-Cited by-同舟云学术

Expression of immune check point gene TIM‑3 in patients newly diagnosed with acute myeloid leukemia: Significance and impact on outcome

Published:2021-02-24 Issue:4 Volume:21 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Kamal Amany¹,Nabih Nermeen²,Elleboudy Nooran³,Radwan Sara¹

Affiliation:

1. Department of Biochemistry, Faculty of Pharmacy, Ain Shams University, Cairo 11566, Egypt

2. Department of Internal Medicine, Clinical Hematology and Bone Marrow Transplantation Unit, Faculty of Medicine, Ain Shams University, Cairo 11591, Egypt

3. Department of Microbiology and Immunology, Faculty of Pharmacy, Ain Shams University, Cairo 11566, Egypt

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-TIM3 chimeric antigen receptor-natural killer cells preferentially target primitive acute myeloid leukemia cells with minimal fratricide and exhaustion;Experimental Hematology & Oncology;2024-07-11

2. Phenotypic changes of γδ T cells in Plasmodium falciparum placental malaria and pregnancy outcomes in women at delivery in Cameroon;Frontiers in Immunology;2024-05-17

3. A T-cell receptor as a promising immunotherapeutic target in acute myeloid leukemia: expression of T cell immunoglobulin and mucin-containing-3 on bone marrow hematopoietic cells;The Egyptian Journal of Haematology;2024-01

4. Activated Tim-3/Galectin-9 participated in the development of multiple myeloma by negatively regulating CD4 T cells;Hematology;2023-12-18

5. Natural Killer Cell Cellular–Based Therapeutic Options for Management of Acute Myeloid Leukemia: Prospect and Challenges;2023-11-06